These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 28818556)

  • 21. Binding Curve Viewer: Visualizing the Equilibrium and Kinetics of Protein-Ligand Binding and Competitive Binding.
    Du Y
    J Chem Inf Model; 2024 May; 64(10):4180-4192. PubMed ID: 38720179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ligand Binding Dynamics for Pre-dimerised G Protein-Coupled Receptor Homodimers: Linear Models and Analytical Solutions.
    White C; Bridge LJ
    Bull Math Biol; 2019 Sep; 81(9):3542-3574. PubMed ID: 29349610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interpreting enzyme and receptor kinetics: keeping it simple, but not too simple.
    Krohn KA; Link JM
    Nucl Med Biol; 2003 Nov; 30(8):819-26. PubMed ID: 14698785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radioligand binding assays and their analysis.
    Maguire JJ; Kuc RE; Davenport AP
    Methods Mol Biol; 2012; 897():31-77. PubMed ID: 22674160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Competitive association binding kinetic assays: a new tool to detect two different binding orientations of a ligand to its target protein under distinct conditions?
    Wittmann HJ; Strasser A
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Jun; 390(6):595-612. PubMed ID: 28220211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analysis of some "insoluble" problems of determining the binding parameters of ligand-receptor interaction and methods of their solving].
    Bobrovnik SA
    Ukr Biokhim Zh (1999); 2004; 76(6):5-28. PubMed ID: 16350740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A chemical kinetic model for ligand binding to identical and independent binding sites in vivo.
    Bond JP; Notides AC
    Anal Biochem; 1988 Nov; 175(1):238-51. PubMed ID: 2854373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Control and stability of ligand receptor interaction in the presence of a competitive compound.
    Tallarida RJ; Freeman KA
    Life Sci; 1991; 48(6):PL19-24. PubMed ID: 1846933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterizing ligand-microtubule binding by competition methods.
    Díaz JF; Buey RM
    Methods Mol Med; 2007; 137():245-60. PubMed ID: 18085234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pharmacological basis of receptor binding.
    Schütz W
    Wien Klin Wochenschr; 1991; 103(15):438-42. PubMed ID: 1656614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Competitive binding kinetics in ligand-receptor-competitor systems. Rate parameters for unlabeled ligands for the formyl peptide receptor.
    Sklar LA; Sayre J; McNeil VM; Finney DA
    Mol Pharmacol; 1985 Oct; 28(4):323-30. PubMed ID: 4058418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A simple and convenient approach for evaluation of the parameters of ligand-receptor interaction. Receptor blocking index and its application.
    Bobrovnik SA
    J Mol Recognit; 2008; 21(2):96-102. PubMed ID: 18383099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simulation of association curves and 'Scatchard' plots of binding reactions where ligand and receptor are degraded or internalized.
    Beck JS; Goren HJ
    J Recept Res; 1983; 3(5):561-77. PubMed ID: 6323708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetic analysis of agonist-receptor interactions. Model for the "irreversible" binding of choleragen to human fibroblasts.
    Osborne JC; Chang PP; Moss J
    J Biol Chem; 1982 Sep; 257(17):10210-4. PubMed ID: 7107601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Series: Utilization of Differential Equations and Methods for Solving Them in Medical Physics (3)].
    Murase K
    Igaku Butsuri; 2016; 35(4):297-306. PubMed ID: 28428465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetics of ligand equilibration between tubular and vesicular parts of the endosome.
    Dagdug L; Berezhkovskii AM; Weiss GH
    Phys Rev E Stat Nonlin Soft Matter Phys; 2004 Jan; 69(1 Pt 1):012902. PubMed ID: 14995658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ligand accumulation in autocrine cell cultures.
    Monine MI; Berezhkovskii AM; Joslin EJ; Wiley HS; Lauffenburger DA; Shvartsman SY
    Biophys J; 2005 Apr; 88(4):2384-90. PubMed ID: 15653719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimation of ligand binding parameters by simultaneous fitting of association and dissociation data: a Monte Carlo simulation study.
    Karlsson MO; Neil A
    Mol Pharmacol; 1989 Jan; 35(1):59-66. PubMed ID: 2913484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental design and estimation of parameters in complex radioligand binding systems.
    Staschen CM; Homer LD
    J Pharmacokinet Biopharm; 1996 Dec; 24(6):589-609. PubMed ID: 9300352
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.